Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Jan;4(1):79–84. doi: 10.1128/cdli.4.1.79-84.1997

Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locus.

S J Greenberg 1, K Fujihara 1, S M Selkirk 1, F Yu 1, T L Du 1, N Glenister 1, P Hohmann 1, M H Rickert 1, P O Spence 1, C E Miller 1, L D Jacobs 1
PMCID: PMC170480  PMID: 9008286

Abstract

A polymorphic (TGCG)n, tetranucleotide repeat was discovered juxtaposed to the (GT)n dinucleotide repeat that comprises the tumor necrosis factor a microsatellite (TNF) located telomeric to the tumor necrosis factor/lymphotoxin gene cluster. The degree of complexity of this compound tetra-,dinucleotide microsatellite consists of 16 potential alleles of combined length ranging from 24 to 54 bp. The pattern of frequencies of individual alleles belonging to the compound TNFa microsatellite was established from 52 healthy volunteers and was found to be highly heterogeneous. The data diverges significantly from previously published statistics that recognized only a simple variable dinucleotide tandem repeat. The newly recognized compound tetra-, dinucleotide TNFa microsatellite polymorphism establishes a more accurate genetic basis to explore potential linkage with disease susceptibility genes located within this region of the class III major histocompatibility complex. In addition, variable tumor necrosis factor and lymphotoxin production may reflect the more complex polymorphic nature of this microsatellite region. Finally, compound microsatellites probably exist elsewhere, throughout the human genome. Recognition of their presence may have a considerable impact on the validity of past and future microsatellite-based genetic analyses.

Full Text

The Full Text of this article is available as a PDF (209.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Moulds J. M. HLA class III molecules and autoimmune rheumatic diseases. Clin Exp Rheumatol. 1991 May-Jun;9(3):289–296. [PubMed] [Google Scholar]
  2. Badenhoop K., Schwarz G., Trowsdale J., Lewis V., Usadel K. H., Gale E. A., Bottazzo G. F. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1989 Jul;32(7):445–448. doi: 10.1007/BF00271265. [DOI] [PubMed] [Google Scholar]
  3. Bendtzen K., Morling N., Fomsgaard A., Svenson M., Jakobsen B., Odum N., Svejgaard A. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol. 1988 Nov;28(5):599–606. doi: 10.1111/j.1365-3083.1988.tb01492.x. [DOI] [PubMed] [Google Scholar]
  4. Bettinotti M. P., Hartung K., Deicher H., Messer G., Keller E., Weiss E. H., Albert E. D. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics. 1993;37(6):449–454. doi: 10.1007/BF00222469. [DOI] [PubMed] [Google Scholar]
  5. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. doi: 10.1056/NEJM198702123160705. [DOI] [PubMed] [Google Scholar]
  6. Bowman C. A., Nelson R. A. Human leukocytic antigens in autoimmune sensorineural hearing loss. Laryngoscope. 1987 Jan;97(1):7–9. doi: 10.1288/00005537-198701000-00003. [DOI] [PubMed] [Google Scholar]
  7. Browning J. L., Ngam-ek A., Lawton P., DeMarinis J., Tizard R., Chow E. P., Hession C., O'Brine-Greco B., Foley S. F., Ware C. F. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell. 1993 Mar 26;72(6):847–856. doi: 10.1016/0092-8674(93)90574-a. [DOI] [PubMed] [Google Scholar]
  8. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chung I. Y., Benveniste E. N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol. 1990 Apr 15;144(8):2999–3007. [PubMed] [Google Scholar]
  10. Crouau-Roy B., Briant L., Bouissou C., Stravropoulos C., Pociot F., Cambon-Thomsen A., Clayton J. Tumor necrosis factor microsatellites in four European populations. Hum Immunol. 1993 Nov;38(3):213–216. doi: 10.1016/0198-8859(93)90543-a. [DOI] [PubMed] [Google Scholar]
  11. Dawkins R. L., Leaver A., Cameron P. U., Martin E., Kay P. H., Christiansen F. T. Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum Immunol. 1989 Oct;26(2):91–97. doi: 10.1016/0198-8859(89)90094-3. [DOI] [PubMed] [Google Scholar]
  12. Degli-Esposti M. A., Abraham L. J., McCann V., Spies T., Christiansen F. T., Dawkins R. L. Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics. 1992;36(6):345–356. doi: 10.1007/BF00218041. [DOI] [PubMed] [Google Scholar]
  13. Degli-Esposti M. A., Andreas A., Christiansen F. T., Schalke B., Albert E., Dawkins R. L. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics. 1992;35(6):355–364. doi: 10.1007/BF00179791. [DOI] [PubMed] [Google Scholar]
  14. Dinarello C. A. Interleukin-1. Rev Infect Dis. 1984 Jan-Feb;6(1):51–95. doi: 10.1093/clinids/6.1.51. [DOI] [PubMed] [Google Scholar]
  15. Dorin J. R., Emslie E., Hanratty D., Farrall M., Gosden J., Porteous D. J. Gene targeting for somatic cell manipulation: rapid analysis of reduced chromosome hybrids by Alu-PCR fingerprinting and chromosome painting. Hum Mol Genet. 1992 Apr;1(1):53–59. doi: 10.1093/hmg/1.1.53. [DOI] [PubMed] [Google Scholar]
  16. Fugger L., Morling N., Ryder L. P., Georgsen J., Jakobsen B. K., Svejgaard A., Andersen V., Oxholm P., Karup Pedersen F., Friis J. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens. 1989 Jul;34(1):17–22. doi: 10.1111/j.1399-0039.1989.tb01712.x. [DOI] [PubMed] [Google Scholar]
  17. Fugger L., Morling N., Ryder L. P., Platz P., Georgsen J., Jakobsen B. K., Svejgaard A., Dalhoff K., Ranek L. NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol. 1989 Aug;30(2):185–189. doi: 10.1111/j.1365-3083.1989.tb01200.x. [DOI] [PubMed] [Google Scholar]
  18. Fugger L., Morling N., Sandberg-Wollheim M., Ryder L. P., Svejgaard A. Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis. J Neuroimmunol. 1990 Apr;27(1):85–88. doi: 10.1016/0165-5728(90)90140-i. [DOI] [PubMed] [Google Scholar]
  19. Honchel R., McDonnell S., Schaid D. J., Thibodeau S. N. Tumor necrosis factor-alpha allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer. Cancer Res. 1996 Jan 1;56(1):145–149. [PubMed] [Google Scholar]
  20. Iris F. J., Bougueleret L., Prieur S., Caterina D., Primas G., Perrot V., Jurka J., Rodriguez-Tome P., Claverie J. M., Dausset J. Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nat Genet. 1993 Feb;3(2):137–145. doi: 10.1038/ng0293-137. [DOI] [PubMed] [Google Scholar]
  21. Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233–1237. doi: 10.1073/pnas.87.3.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jeffreys A. J., Wilson V., Neumann R., Keyte J. Amplification of human minisatellites by the polymerase chain reaction: towards DNA fingerprinting of single cells. Nucleic Acids Res. 1988 Dec 9;16(23):10953–10971. doi: 10.1093/nar/16.23.10953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jongeneel C. V., Briant L., Udalova I. A., Sevin A., Nedospasov S. A., Cambon-Thomsen A. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9717–9721. doi: 10.1073/pnas.88.21.9717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991 Dec;10(13):4025–4031. doi: 10.1002/j.1460-2075.1991.tb04978.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Marshall B., Leelayuwat C., Abraham L. J., Pinelli M., Dawkins R. L. Large transcripts and sequence from a polymorphic 170 kb MHC region implicated in susceptibility to autoimmune disease. Immunogenetics. 1994;39(1):15–20. doi: 10.1007/BF00171792. [DOI] [PubMed] [Google Scholar]
  26. Messer G., Spengler U., Jung M. C., Honold G., Blömer K., Pape G. R., Riethmüller G., Weiss E. H. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991 Jan 1;173(1):209–219. doi: 10.1084/jem.173.1.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Milner C. M., Campbell R. D. Genes, genes and more genes in the human major histocompatibility complex. Bioessays. 1992 Aug;14(8):565–571. doi: 10.1002/bies.950140814. [DOI] [PubMed] [Google Scholar]
  28. Nedospasov S. A., Udalova I. A., Kuprash D. V., Turetskaya R. L. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol. 1991 Aug 1;147(3):1053–1059. [PubMed] [Google Scholar]
  29. Partanen J., Koskimies S. Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumour necrosis factor beta) gene. Scand J Immunol. 1988 Sep;28(3):313–316. doi: 10.1111/j.1365-3083.1988.tb01454.x. [DOI] [PubMed] [Google Scholar]
  30. Pociot F., Briant L., Jongeneel C. V., Mölvig J., Worsaae H., Abbal M., Thomsen M., Nerup J., Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993 Jan;23(1):224–231. doi: 10.1002/eji.1830230135. [DOI] [PubMed] [Google Scholar]
  31. Roth M. P., Nogueira L., Coppin H., Clanet M., Clayton J., Cambon-Thomsen A. Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol. 1994 Apr;51(1):93–99. doi: 10.1016/0165-5728(94)90133-3. [DOI] [PubMed] [Google Scholar]
  32. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Santamaria P., Gehrz R. C., Bryan M. K., Barbosa J. J. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol. 1989 Aug 1;143(3):913–922. [PubMed] [Google Scholar]
  34. Schaffer F. M., Palermos J., Zhu Z. B., Barger B. O., Cooper M. D., Volanakis J. E. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8015–8019. doi: 10.1073/pnas.86.20.8015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Selmaj K. W., Raine C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988 Apr;23(4):339–346. doi: 10.1002/ana.410230405. [DOI] [PubMed] [Google Scholar]
  36. Selmaj K., Raine C. S., Cannella B., Brosnan C. F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest. 1991 Mar;87(3):949–954. doi: 10.1172/JCI115102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Selmaj K., Raine C. S., Cross A. H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol. 1991 Nov;30(5):694–700. doi: 10.1002/ana.410300510. [DOI] [PubMed] [Google Scholar]
  38. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  39. Udalova I. A., Nedospasov S. A., Webb G. C., Chaplin D. D., Turetskaya R. L. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics. 1993 Apr;16(1):180–186. doi: 10.1006/geno.1993.1156. [DOI] [PubMed] [Google Scholar]
  40. Webb G. C., Chaplin D. D. Genetic variability at the human tumor necrosis factor loci. J Immunol. 1990 Aug 15;145(4):1278–1285. [PubMed] [Google Scholar]
  41. Wilson A. G., de Vries N., Pociot F., di Giovine F. S., van der Putte L. B., Duff G. W. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993 Feb 1;177(2):557–560. doi: 10.1084/jem.177.2.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ziegle J. S., Su Y., Corcoran K. P., Nie L., Mayrand P. E., Hoff L. B., McBride L. J., Kronick M. N., Diehl S. R. Application of automated DNA sizing technology for genotyping microsatellite loci. Genomics. 1992 Dec;14(4):1026–1031. doi: 10.1016/s0888-7543(05)80126-0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES